On November 20, 2025, a series of bills aimed at comprehensively updating regulations in the field of countering the illegal use of insider information and market manipulation were submitted to the State Duma of the Russian Federation. The amendments affected the Law on Insider Information and the Law on Organized Trading, as well as related provisions of the Code of Administrative Offences and the Criminal Code of the Russian Federation. The legislative initiative was introduced by a group of State Duma deputies together with senators of the Russian Federation.

On 27 November 2025, Decree of the Government of the Russian Federation No. 1894 “On the Approval of the Rules for Coordinating with the Federal Security Service of the Russian Federation the Participation of Foreign...” (hereinafter referred to as the “FSB Coordination Rules”) was published. It stipulates that civil-purpose scientific research, experimental design, and technological work (hereinafter referred to as “Work”) involving foreign citizens and foreign organizations, as well as Russian organizations whose participants (founders) include foreign citizens and/or foreign organizations, must be coordinated with the FSB in the fields of scientific and/or scientific-technical activities and experimental development. This coordination is carried out by submitting information to the Russian Ministry of Science and Higher Education through the Unified State Information System for Accounting of Research, Development, and Technological Work (EGISU NIOKTR).

On 24 November 2025, the Delhi High Court issued a judgment in a major patent dispute Medilabo Rfp Inc. v. The Controller of Patents C.A. (Comm.Ipd-Pat) 16/2024, concerning the patent eligibility of a drug for neurodegenerative diseases.

On December 5, 2025, the Bank of Russia announced the partial removal of previously established limits on foreign currency transfers abroad for Russian citizens and individuals who are non-residents from friendly countries. The relaxations came into effect on December 8, 2025.

In June 2024, the pharmaceutical industry faced a new practice by the Federal Antimonopoly Service (FAS), which began to consistently recognize the introduction of generic drugs onto the market as unfair competition.

On 4 December 2025 the results of the annual Pravo-300 law firms’ ranking were announced at an awarding ceremony at The Carlton Hotel in Moscow. This year Lidings expertise is highly praised in 17 key practice areas.

Lidings Managing Partner Andrey Zelenin will take part in the annual conference on law firm management: "The Future of the Legal Business in Russia. Strategy and Challenges of the Mid-2020s."

The event, supported by the Russian Arbitration Association (RAA), will unite the leadership of Russia's leading legal market players.

On 17 November 2025, the Russian Ministry of Health published the Order No. 669n (hereinafter - the "Order") approving the procedure for healthcare professionals to prescribe dietary supplements when providing medical care to citizens.

On October 24, 2025, the Government of the Russian Federation submitted to the State Duma of the Russian Federation Draft Law No. 1050649-8 " On Amendments to the Federal Law "On Investment Partnerships "(hereinafter - the "IP Law") and Fundamentals of Legislation of the Russian Federation on Notaries" (hereinafter - the "Bill").